Key Highlights
- Hackensack Meridian Health partners with K Health to launch HMH 24/7, an AI-powered primary care platform.
- HMH 24/7 offers seamless virtual and in-person care integration.
- Patients benefit from personalized care with 24/7 access and a dedicated clinician.
- The platform integrates with Hackensack Meridian Health’s EMR system, ensuring continuity of care.
Source: Business Wire
Notable Quotes
- “Our focus on extending our high-quality primary care, leveraging AI-driven technology, and 24/7 care, proves our commitment to open access to primary care in New Jersey.” — Daniel Varga, MD, Chief Physician Executive at Hackensack Meridian Health
- “We know patients want virtual care, but understanding how to deliver that in the context of a larger health system is where HMH 24/7 stands us apart.” — Robert Garrett, CEO at Hackensack Meridian Health
- “K Health’s expert clinical AI solution is already live in major health systems across the country, relieving clinical burnout, reducing administrative burden, increasing appointment availability, and improving outcomes.” — Ran Shaul, Co-founder & Chief Product Officer at K Health
SoHC's Take
The launch of HMH 24/7 marks a significant evolution in patient care, emphasizing the growing demand for hybrid models that merge virtual and in-person healthcare. Hackensack Meridian Health is taking a bold step by integrating AI with traditional care models, positioning itself as a leader in improving healthcare accessibility and outcomes. This partnership with K Health not only enhances efficiency by reducing administrative tasks but also empowers clinicians with data-driven insights, improving patient experiences and satisfaction across New Jersey’s largest health network.
Heading
Key Highlights Heidi Chen named Chief Legal Officer at GeneDx, effective November 25, 2024. Brings over 30 years of legal ...
Key Highlights TA Associates completes a strategic growth investment in Vee Healthtek. Vee Healthtek to expand services in healthcare technology ...
Key Highlights Dr. Laura Aguilar named Chief Medical Officer at Diakonos Oncology. DOC1021 dendritic cell vaccine to enter Phase 2 ...
Key Highlights Deb Autor, former FDA Deputy Commissioner, joins Hims & Hers Board of Directors. Janet Stevens, pharmaceutical quality expert, named Global ...
Key Highlights Dr. Gregg A. Pratt joins as Chief Regulatory and Quality Assurance Officer to oversee regulatory and quality functions. Phase ...
Key Highlights Revisto secures $4M in seed funding led by LiveOak Ventures, joined by Eli Lilly and others. AI-driven platform ...
